Reduced expression and capacity of the striatal high-affinity choline transporter in hyperdopaminergic mice

Neuroscience

Volumn 141, Issue 1, 2006, Pages 379-389

  Parikh, V ^a   Apparsundaram, S ^b   Kozak, R ^a   Richards, J B ^c   Sarter, M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c RESEARCH INSTITUTE ON ADDICTIONS   (United States)

Author keywords

Acetylcholine; Choline transporter; Hyperdopaminergic mice; Striatum

Indexed keywords

ACETYLCHOLINE; CARRIER PROTEIN; CHOLINE; CHOLINE TRANSPORTER; DOPAMINE; DOPAMINE TRANSPORTER; HEMICHOLINIUM 3; NEUROTRANSMITTER UPTAKE INHIBITOR;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BRAIN LEVEL; COMPARATIVE STUDY; CORPUS STRIATUM; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHODOLOGY; MICRODIALYSIS; MOUSE; MOUSE MUTANT; PHYSIOLOGY; SYNAPTOSOME; WESTERN BLOTTING;

ACETYLCHOLINE; ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; BRAIN CHEMISTRY; CHOLINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HEMICHOLINIUM 3; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, KNOCKOUT; MICRODIALYSIS; NEUROTRANSMITTER UPTAKE INHIBITORS; SYNAPTOSOMES;

EID: 33749077779     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.03.055     Document Type: Article

References (53)

1. Abercrombie ED, DeBoer P (1997) Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism. J Neurosci 17:8498-8505.
2. Acquas E, Di Chiara G (1999) Local application of SCH 39166 reversibly and dose-dependently decreases acetylcholine release in the rat striatum. Eur J Pharmacol 383:275-279.
3. Apparsundaram S, Martinez V, Parikh V, Kozak R, Sarter M (2005) Increased capacity and density of choline transporters situated in synaptic membranes of the right medial prefrontal cortex of attentional task-performing rats. J Neurosci 25:3851-3856.
4. Atweh S, Simon JR, Kuhar MJ (1975) Utilization of sodium-dependent high affinity choline uptake in vitro as a measure of the activity of cholinergic neurons in vivo. Life Sci 17:1535-1544.
5. Beeri R, Le Novere N, Mervis R, Huberman T, Grauer E, Changeux JP, Soreq H (1997) Enhanced hemicholinium binding and attenuated dendrite branching in cognitively impaired acetylcholinesterasetransgenic mice. J Neurochem 69:2441-2451.
6. Berridge KC, Aldridge JW, Houchard KR, Zhuang X (2005) Sequential super-stereotypy of an instinctive fixed action pattern in hyperdopaminergic mutant mice: a model of obsessive compulsive disorder and Tourette's. BMC Biol 3:4.
7. Bickerdike MJ, Abercrombie ED (1997) Striatal acetylcholine release correlates with behavioral sensitization in rats withdrawn from chronic amphetamine. J Pharmacol Exp Ther 282:818-826.
8. Blanchet F, Kemel ML, Gauchy C, Desban M, Perez S, Glowinski J (1997) N-methyl-D-aspartate-evoked release of [3H]acetylcholine in striatal compartments of the rat: regulatory roles of dopamine and GABA. Neuroscience 81:113-127.
9. Blazquez PM, Fujii N, Kojima J, Graybiel AM (2002) A network representation of response probability in the striatum. Neuron 33:973-982.
10. Brandon EP, Mellott T, Pizzo DP, Coufal N, D'Amour KA, Gobeske K, Lortie M, Lopez-Coviella I, Berse B, Thal LJ, Gage FH, Blusztajn JK (2004) Choline transporter 1 maintains cholinergic function in choline acetyltransferase haploinsufficiency. J Neurosci 24:5459-5466.
11. Burmeister JJ, Gerhardt GA (2001) Self-referencing ceramic-based multisite microelectrodes for the detection and elimination of interferences from the measurement of L-glutamate and other analytes. Anal Chem 73:1037-1042.
12. Burmeister JJ, Palmer M, Gerhardt GA (2003) Ceramic-based multisite electrode array for rapid choline measures in brain tissue. Anal Chim Acta 481:65-74.
13. Cagniard B, Balsam PD, Brunner D, Zhuang X (2005) Mice with chronically elevated dopamine exhibit enhanced motivation, but not learning, for a food reward. Neuropsychopharmacology [Epub ahead of print]. http://www.nature.com.
14. Calabresi P, Centonze D, Gubellini P, Pisani A, Bernardi G (1998) Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation. Eur J Neurosci 10: 2887-2895.
15. Calabresi P, Centonze D, Gubellini P, Pisani A, Bernardi G (2000) Acetylcholine-mediated modulation of striatal function. Trends Neurosci 23:120-126.
16. Cass WA, Zahniser NR, Flach KA, Gerhardt GA (1993) Clearance of exogenous dopamine in rat dorsal striatum and nucleus accumbens: role of metabolism and effects of locally applied uptake inhibitors. J Neurochem 61:2269-2278.
17. Daws LC, Toney GM, Davis DJ, Gerhardt GA, Frazer A (1997) In vivo chronoamperometric measurements of the clearance of exogenously applied serotonin in the rat dentate gyrus. J Neurosci Methods 78:139-150.
18. De Boer P, Damsma G, Schram Q, Stoof JC, Zaagsma J, Westerink BH (1992) The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis. The importance of the post-surgery interval. Naunyn Schmiedebergs Arch Pharmacol 345:144-152.
19. Ferguson SM, Blakely RD (2004) The choline transporter resurfaces: new roles for synaptic vesicles. Mol Intervent 4:22-37.
20. Ferguson SM, Bazalakova M, Savchenko V, Tapia JC, Wright J, Blakely RD (2004) Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice. Proc Natl Acad Sci U S A 101:8762-8767.
21. Ferguson SM, Savchenko V, Apparsundaram S, Zwick M, Wright J, Heilman CJ, Yi H, Levey AI, Blakely RD (2003) Vesicular localization and activity-dependent trafficking of presynaptic choline transporters. J Neurosci 23:9697-9709.
22. Friedemann MN, Gerhardt GA (1992) Regional effects of aging on dopaminergic function in the Fischer-344 rat. Neurobiol Aging 13:325-332.
23. Gates J Jr, Ferguson SM, Blakely RD, Apparsundaram S (2004) Regulation of choline transporter surface expression and phosphorylation by protein kinase C and protein phosphatase 1/2A. J Pharmacol Exp Ther 310:536-545.
24. Greenwald AG, Gonzalez R, Harris RJ, Guthrie D (1996) Effect sizes and p values: what should be reported and what should be replicated. Psychophysiology 33:175-183.
25. Guyenet P, Lefresne P, Rossier J, Beaujouan JC, Glowinski J (1973) Effect of sodium, hemicholinium-3 and antiparkinson drugs on (14C)acetylcholine synthesis and (3H)choline uptake in rat striatal synaptosomes. Brain Res 62:523-529.
26. Kaneko S, Hikida T, Watanabe D, Ichinose H, Nagatsu T, Kreitman RJ, Pastan I, Nakanishi S (2000) Synaptic integration mediated by striatal cholinergic interneurons in basal ganglia function. Science 289:633-637.
27. Kitabatake Y, Hikida T, Watanabe D, Pastan I, Nakanishi S (2003) Impairment of reward-related learning by cholinergic cell ablation in the striatum. Proc Natl Acad Sci U S A 100:7965-7970.
28. Klein J, Weichel O, Ruhr J, Dvorak C, Loffelholz K (2002) A homeostatic mechanism counteracting K(+)-evoked choline release in adult brain. J Neurochem 80:843-849.
29. Kozak R, Bruno JP, Sarter M (2006) Augmented prefrontal acetylcholine release during challenged attentional performance. Cereb Cortex 16:9-17.
30. Lockman PR, Allen DD (2002) The transport of choline. Drug Dev Ind Pharm 28:749-771.
31. Loffelholz K, Klein J (2004) How is the brain protected against excess choline concentrations? In: Cholinergic mechanisms: function and dysfunction (Silman I, Soreq H, Anglister L, Michaelson D, Fisher A, eds), pp 395-398. London: Taylor and Francis.
32. Loffelholz K, Klein J, Koppen A (1993) Choline, a precursor of acetylcholine and phospholipids in the brain. In: Cholinergic function and dysfunction (Cuello AC, ed), pp 197-200. Amsterdam: Elsevier.
33. Manaker S, Wieczorek CM, Rainbow TC (1986) Identification of sodiumdependent, high-affinity choline uptake sites in rat brain with [3H]hemicholinium-3. J Neurochem 46:483-488.
34. Maurice N, Mercer J, Chan CS, Hernandez-Lopez S, Held J, Tkatch T, Surmeier DJ (2004) D2 dopamine receptor-mediated modulation of voltage-dependent Na+ channels reduces autonomous activity in striatal cholinergic interneurons. J Neurosci 24:10289-10301.
35. Parikh V, Sarter M (2006) Cortical choline transporter function measured in vivo using choline-sensitive microelectrodes: clearance of endogenous and exogenous choline and effects of removal of cholinergic terminals. J Neurochem 97:488-503.
36. Parikh V, Pomerleau F, Huettl P, Gerhardt GA, Sarter M, Bruno JP (2004) Rapid assessment of in vivo cholinergic transmission by amperometric detection of changes in extracellular choline levels. Eur J Neurosci 20:1545-1554.
37. Pecina S, Cagniard B, Berridge KC, Aldridge JW, Zhuang X (2003) Hyperdopaminergic mutant mice have higher "wanting" but not "liking" for sweet rewards. J Neurosci 23:9395-9402.
38. Perez-Rosello T, Figueroa A, Salgado H, Vilchis C, Tecuapetla F, Guzman JN, Galarraga E, Bargas J (2005) Cholinergic control of firing pattern and neurotransmission in rat neostriatal projection neurons: role of CaV2.1 and CaV2.2 Ca2+ channels. J Neurophysiol 93:2507-2519.
39. Pisani A, Bonsi P, Centonze D, Calabresi P, Bernardi G (2000) Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons. J Neurosci 20:RC69.
40. Ralph-Williams RJ, Paulus MP, Zhuang X, Hen R, Geyer MA (2003) Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system. Biol Psychiatry 53:352-359.
41. Saltarelli MD, Lowenstein PR, Coyle JT (1987) Rapid in vitro modulation of [3H]hemicholinium-3 binding sites in rat striatal slices. Eur J Pharmacol 135:35-40.
42. Sarter M, Parikh V (2005) Choline transporters, cholinergic transmission and cognition. Nat Rev Neurosci 6:48-56.
43. Shen W, Hamilton SE, Nathanson NM, Surmeier DJ (2005) Cholinergic suppression of KCNQ channel currents enhances excitability of striatal medium spiny neurons. J Neurosci 25:7449-7458.
44. Slotkin TA, Nemeroff CB, Bissette G, Seidler FJ (1994) Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies. J Clin Invest 94:696-702.
45. Stoof JC, Drukarch B, de Boer P, Westerink BH, Groenewegen HJ (1992) Regulation of the activity of striatal cholinergic neurons by dopamine. Neuroscience 47:755-770.
46. Tepper JM, Bolam JP (2004) Functional diversity and specificity of neostriatal interneurons. Curr Opin Neurobiol 14:685-692.
47. Umeda Y, Watanabe C, Sumi T (1991) A change in the spontaneous release of endogenous acetylcholine from rat striatal slices after repeated injection of haloperidol. Neurosci Lett 123:9-12.
48. Vetter JM, Jehle T, Heinemeyer J, Franz P, Behrens PF, Jackisch R, Landwehrmeyer GB, Feuerstein TJ (2003) Mice transgenic for exon 1 of Huntington's disease: properties of cholinergic and dopaminergic pre-synaptic function in the striatum. J Neurochem 85:1054-1063.
49. Wightman RM, Amatore C, Engstrom RC, Hale PD, Kristensen EW, Kuhr WG, May LJ (1988) Real-time characterization of dopamine overflow and uptake in the rat striatum. Neuroscience 25: 513-523.
50. Yamada H, Matsumoto N, Kimura M (2004) Tonically active neurons in the primate caudate nucleus and putamen differentially encode instructed motivational outcomes of action. J Neurosci 24:3500-3510.
51. Yasumoto S, Tanaka E, Hattori G, Maeda H, Higashi H (2002) Direct and indirect actions of dopamine on the membrane potential in medium spiny neurons of the mouse neostriatum. J Neurophysiol 87:1234-1243.
52. Zahniser NR, Larson GA, Gerhardt GA (1999) In vivo dopamine clearance rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors. J Pharmacol Exp Ther 289:266-277.
53. Zhuang X, Oosting RS, Jones SR, Gainetdinov RR, Miller GW, Caron MG, Hen R (2001) Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc Natl Acad Sci U S A 98: 1982-1987.